Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma (SLAT)

This study has been completed.
Sponsor:
Information provided by:
Spanish Lung Cancer Group
ClinicalTrials.gov Identifier:
NCT00883480
First received: December 22, 2008
Last updated: April 16, 2009
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
No publications provided by Spanish Lung Cancer Group

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):